Not all nebulizers are created equal: Considerations in choosing a nebulizer for aerosol delivery during mechanical ventilation
R MacLoughlin, I Martin-Loeches - Expert Review of Respiratory …, 2023 - Taylor & Francis
Introduction Aerosol therapy is commonly prescribed in the mechanically ventilated patient.
Jet nebulizers (JN) and vibrating mesh nebulizers (VMN) are the most common nebulizer …
Jet nebulizers (JN) and vibrating mesh nebulizers (VMN) are the most common nebulizer …
Nebuliser type influences both patient-derived bioaerosol emissions and ventilation parameters during mechanical ventilation
M Joyce, JA McGrath, M Mac Giolla Eain, A O'Sullivan… - Pharmaceutics, 2021 - mdpi.com
COVID-19 may lead to serious respiratory complications which may necessitate ventilatory
support. There is concern surrounding potential release of patient-derived bioaerosol during …
support. There is concern surrounding potential release of patient-derived bioaerosol during …
Evaluation of aerosol drug delivery options during adult mechanical ventilation in the COVID-19 era
PJ Naughton, M Joyce, M Mac Giolla Eain, A O'Sullivan… - Pharmaceutics, 2021 - mdpi.com
Drug delivery devices used for aerosol therapy during mechanical ventilation to ease the
symptoms of respiratory diseases provide beneficial treatment but can also pose challenges …
symptoms of respiratory diseases provide beneficial treatment but can also pose challenges …
Evaluation of aerosol therapy during the escalation of care in a model of adult cystic fibrosis
E Fernandez Fernandez, M Joyce, A O'Sullivan… - Antibiotics, 2021 - mdpi.com
Lung disease is the main cause of morbidity and mortality in cystic fibrosis (CF). CF patients
inhale antibiotics regularly as treatment against persistent bacterial infections. The goal of …
inhale antibiotics regularly as treatment against persistent bacterial infections. The goal of …
An in vitro visual study of fugitive aerosols released during aerosol therapy to an invasively ventilated simulated patient
M Mac Giolla Eain, M Joyce, R MacLoughlin - Drug Delivery, 2021 - Taylor & Francis
COVID-19 can cause serious respiratory complications resulting in the need for invasive
ventilatory support and concurrent aerosol therapy. Aerosol therapy is considered a high risk …
ventilatory support and concurrent aerosol therapy. Aerosol therapy is considered a high risk …
[HTML][HTML] An in vitro investigation into the release of fugitive medical aerosols into the environment during manual ventilation
MMG Eain, M Joyce, A O'Sullivan, JA McGrath… - Journal of Hospital …, 2021 - Elsevier
Background During manual resuscitation, nebulizer therapy may be used to deliver
therapeutics to patients in respiratory distress. However, the devices used to generate and …
therapeutics to patients in respiratory distress. However, the devices used to generate and …
[HTML][HTML] Effect of nebuliser and patient interface type on fugitive medical aerosol emissions in adult and paediatric patients
C O'Toole, JA McGrath, M Joyce, A O'Sullivan… - European Journal of …, 2023 - Elsevier
Background Open circuit aerosol therapy is associated with the potential for fugitive
emissions of medical aerosol. Various nebulisers and interfaces are used in respiratory …
emissions of medical aerosol. Various nebulisers and interfaces are used in respiratory …
Comparison Of Different Exhalation Filters In Protection Against Fugitive Aerosol During Nebulizer Treatments: An In-vitro Study
LS Chen - 2021 - scholarworks.gsu.edu
Background: Aerosol escaping to the environment during nebulization treatments is called
fugitive aerosol. Placing a filter at the exhalation outlet is one way to prevent unintended …
fugitive aerosol. Placing a filter at the exhalation outlet is one way to prevent unintended …
[HTML][HTML] COVID-19 Vaccine Can Now Be Inhaled, Thanks to Breakthrough Partnership Between Aerogen® and CanSinoBIO.
AZN Worth, B Story, C Magazine - corpradar.org
In 2022 Convidecia Air™ was granted Emergency Use Authorization as a booster dose by
the National Medical Products Administration of China (“NMPA”). On October 25, Shanghai …
the National Medical Products Administration of China (“NMPA”). On October 25, Shanghai …
[HTML][HTML] World-First Inhaled COVID-19 Vaccine, Developed in Partnership Between Aerogen® and CanSinoBIO, First Public Booster Immunization in China.
L Lézard - lelezard.com
In 2022 Convidecia Airtm was granted Emergency Use Authorization as a booster dose by
the National Medical Products Administration of China (" NMPA"). On October 25 th …
the National Medical Products Administration of China (" NMPA"). On October 25 th …